Terms: = Bone cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS
393 results:
1. Effectiveness of Carbon Ion Radiotherapy for bone and Soft Tissue Sarcoma in Older Patients.
Kinoshita H; Yonemoto T; Yamada S; Imai R
Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
[TBL] [Abstract] [Full Text] [Related]
2. The Effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma- does it influence prognosis?
Fromm J; Klein A; Kirilova M; Lindner LH; Nachbichler S; Holzapfel BM; Goller SS; Knösel T; Dürr HR
BMC Cancer; 2024 Mar; 24(1):303. PubMed ID: 38448852
[TBL] [Abstract] [Full Text] [Related]
3. Does Preoperative Bilsky Score Predict Outcome Following Surgical Resection of Primary Tumors of the Spine?
Chen JW; Chanbour H; Bowers M; Bendfeldt GA; Gangavarapu LS; Jonzzon S; Roth SG; Abtahi AM; Zuckerman SL; Stephens BF
World Neurosurg; 2024 Apr; 184():e111-e120. PubMed ID: 38244684
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study.
Luo L; Xu N; Liu Y; Zhong S; Yang S; Chen X
Int J Gynaecol Obstet; 2024 Apr; 165(1):176-187. PubMed ID: 38013509
[TBL] [Abstract] [Full Text] [Related]
5. Role of 18F-NaF PET/CT in bone metastases.
Zhang-Yin J; Panagiotidis E
Q J Nucl Med Mol Imaging; 2023 Dec; 67(4):249-258. PubMed ID: 37750848
[TBL] [Abstract] [Full Text] [Related]
6. Radiation exposure and leukaemia risk among cohorts of persons exposed to low and moderate doses of external ionising radiation in childhood.
Little MP; Wakeford R; Zablotska LB; Borrego D; Griffin KT; Allodji RS; de Vathaire F; Lee C; Brenner AV; Miller JS; Campbell D; Pearce MS; Sadetzki S; Doody MM; Holmberg E; Lundell M; French B; Adams MJ; Berrington de González A; Linet MS
Br J Cancer; 2023 Oct; 129(7):1152-1165. PubMed ID: 37596407
[TBL] [Abstract] [Full Text] [Related]
7. The burden and trend of diseases and their risk factors in Australia, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Australia Collaborators
Lancet Public Health; 2023 Aug; 8(8):e585-e599. PubMed ID: 37516475
[TBL] [Abstract] [Full Text] [Related]
8. Nomograms for predicting overall survival in colorectal cancer patients with metastasis to the liver, lung, bone, and brain.
Wang H; Shan X; Zhang M; Qian K; Shen Z; Zhou W
Cancer Causes Control; 2023 Dec; 34(12):1059-1072. PubMed ID: 37486401
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistent prostate cancer.
Vidal M; Cárdenas-Perilla R; Delgado A; Morón S; Londoño Blair JL; Vega I; Correa Ochoa JJ; Rojas J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(5):310-318. PubMed ID: 37419250
[TBL] [Abstract] [Full Text] [Related]
10. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
[TBL] [Abstract] [Full Text] [Related]
11. [Prognostic value and mechanism of long non-coding RNA DLEU1 in osteosarcoma].
Zhang JJ; Yang P; Shang XQ
Zhongguo Gu Shang; 2023 Jun; 36(6):559-64. PubMed ID: 37366099
[TBL] [Abstract] [Full Text] [Related]
12. HORMONE-RECEPTOR -POSITIVE BREAST cancer: DIFFERENT PROGNOSIS OF bone METASTASIS AMONG MOLECULAR SUBTYPES.
Tevzadze M; Kakhadze S; Baramia M; Rukhadze T; Khatashvili Z; Mirzaey S
Georgian Med News; 2023 Mar; (336):54-58. PubMed ID: 37166880
[TBL] [Abstract] [Full Text] [Related]
13. Inter-observer variability between readers in detection of bone metastases comparing different modalities; PET/CT, SPECT/CT and planar bone scintigraphy.
Bashank N; Hussein A; Mekawy M; Askar H
Nucl Med Commun; 2023 Jul; 44(7):604-612. PubMed ID: 37114413
[TBL] [Abstract] [Full Text] [Related]
14. Frequency of superscan on bone scintigraphy: A systematic review.
Kovacsne A; Kozon I; Bentestuen M; Zacho HD
Clin Physiol Funct Imaging; 2023 Sep; 43(5):297-304. PubMed ID: 37070619
[TBL] [Abstract] [Full Text] [Related]
15. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate cancer: A Systematic Review and Meta-analysis.
Chow KM; So WZ; Lee HJ; Lee A; Yap DWT; Takwoingi Y; Tay KJ; Tuan J; Thang SP; Lam W; Yuen J; Lawrentschuk N; Hofman MS; Murphy DG; Chen K
Eur Urol; 2023 Jul; 84(1):36-48. PubMed ID: 37032189
[TBL] [Abstract] [Full Text] [Related]
16. bone Metastases Detection in Patients with Breast cancer: Does bone Scintigraphy Add Information to PET/CT?
Cristo Santos J; Henriques Abreu M; Seoane Santos M; Duarte H; Alpoim T; Próspero I; Sousa S; Henriques Abreu P
Oncologist; 2023 Aug; 28(8):e600-e605. PubMed ID: 37029988
[TBL] [Abstract] [Full Text] [Related]
17. Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System.
da Silva ACB; de Toledo LGM; de Carvalho Fernandes R; Ziroldo AR; Sawczyn GV; Alarcon ST; Lewin F
Ann Surg Oncol; 2023 Jul; 30(7):4541-4549. PubMed ID: 36995451
[TBL] [Abstract] [Full Text] [Related]
18. Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan.
Liu HL; Chen YH; Chung CH; Wu GJ; Tsao CH; Sun CA; Chien WC; Hung CT
Balkan Med J; 2023 Mar; 40(2):131-138. PubMed ID: 36804217
[TBL] [Abstract] [Full Text] [Related]
19. Deep learning based identification of bone scintigraphies containing metastatic bone disease foci.
Ibrahim A; Vaidyanathan A; Primakov S; Belmans F; Bottari F; Refaee T; Lovinfosse P; Jadoul A; Derwael C; Hertel F; Woodruff HC; Zacho HD; Walsh S; Vos W; Occhipinti M; Hanin FX; Lambin P; Mottaghy FM; Hustinx R
Cancer Imaging; 2023 Jan; 23(1):12. PubMed ID: 36698217
[TBL] [Abstract] [Full Text] [Related]
20. Clinical significance of EVI-1 gene expression and aberrations in patient with de-novo acute myeloid and acute lymphoid leukemia.
Nabil R; Abdellateif MS; Gamal H; Hassan NM; Badawy RH; Ghareeb M; El Ashry MS
Leuk Res; 2023 Mar; 126():107019. PubMed ID: 36657369
[TBL] [Abstract] [Full Text] [Related]
[Next]
